chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Ultrasound scan
Clinical narrative: I got my vaccine in my left arm. Approx. 2 days later, I couldn't lift my arm and that continued for a week or so. I went to my chiropractor thinking she could adjust my arm. She could feel all my lymph nodes on my left side were inflamed. I went back to her probably 3 times for that. I also spoke to my PCP about it. I was in touch with him but never saw him. I talked to him over the phone and via email. It lasted for approximately 3 weeks, and he didn't want me to get the 2nd vaccine unless it subsided. At week 4, it subsided, and I got my 2nd vaccine. Also, during this time, my left breast was also swollen, and I was supposed to get a mammogram, but I was advised by PCP to wait on that. Couldn't lift my arm during this time and felt like my arm would fall off. Again, that lasted for maybe 3 1/2 weeks but then I was fine. I got my 2nd vaccine and that one was actually fine. On 03/11/2021 I texted my PCP: pain radiates in shoulder and down to fingers, tingling in tongue, pain in neck. On 04/06/2021 I texted my PCP: let my PCP know about my 2nd vaccine and that everything was fine. On 08/2021 I had mammogram (was fine, but still had discomfort in the left breast), told me to get an ultrasound and that came back okay as well. My left arm will still bother me every now and then.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Atrial fibrillation, COVID-19, Cough
Clinical narrative: 88-year-old female with a history of hypertension, diabetes presents with generalized weakness. Patient has had cough, progressive weakness for the past 9 days. Patient presented to the primary care office 6 days ago and was diagnosed with a upper respiratory infection and given a Z-Pak. Patient has been taking this for the past 5 days with no improvement. Overnight patient has significant worsening of her weakness. Patient not initially complaining of any shortness of breath. On EMS arrival patient found to be 39% on room air. Patient is placed on 15 L nonrebreather O2 improved to 77%. Patient has no other complaints. Patient is vaccinated with Pfizer vaccine ×2. o New-onset atrial fibrillation; CHADS2Vasc =5.  ? Repeat limited 2D echo unchanged from 11/19/21 echo o DCCV 12/1 due to afib RVR with hypotension o Essential hypertension; BP labile, currently requiring vasopressors o DMII o Acute hypoxic respiratory failure secondary to COVID on CPAP o NC anemia 2/2 suspected GIB patient expired 12/7/2021
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Essential hypertension, Gastrointestinal haemorrhage, Hypotension, Influenza A virus test negative
Clinical narrative: 88-year-old female with a history of hypertension, diabetes presents with generalized weakness. Patient has had cough, progressive weakness for the past 9 days. Patient presented to the primary care office 6 days ago and was diagnosed with a upper respiratory infection and given a Z-Pak. Patient has been taking this for the past 5 days with no improvement. Overnight patient has significant worsening of her weakness. Patient not initially complaining of any shortness of breath. On EMS arrival patient found to be 39% on room air. Patient is placed on 15 L nonrebreather O2 improved to 77%. Patient has no other complaints. Patient is vaccinated with Pfizer vaccine ×2. o New-onset atrial fibrillation; CHADS2Vasc =5.  ? Repeat limited 2D echo unchanged from 11/19/21 echo o DCCV 12/1 due to afib RVR with hypotension o Essential hypertension; BP labile, currently requiring vasopressors o DMII o Acute hypoxic respiratory failure secondary to COVID on CPAP o NC anemia 2/2 suspected GIB patient expired 12/7/2021
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Normocytic anaemia, Positive airway pressure therapy, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: 88-year-old female with a history of hypertension, diabetes presents with generalized weakness. Patient has had cough, progressive weakness for the past 9 days. Patient presented to the primary care office 6 days ago and was diagnosed with a upper respiratory infection and given a Z-Pak. Patient has been taking this for the past 5 days with no improvement. Overnight patient has significant worsening of her weakness. Patient not initially complaining of any shortness of breath. On EMS arrival patient found to be 39% on room air. Patient is placed on 15 L nonrebreather O2 improved to 77%. Patient has no other complaints. Patient is vaccinated with Pfizer vaccine ×2. o New-onset atrial fibrillation; CHADS2Vasc =5.  ? Repeat limited 2D echo unchanged from 11/19/21 echo o DCCV 12/1 due to afib RVR with hypotension o Essential hypertension; BP labile, currently requiring vasopressors o DMII o Acute hypoxic respiratory failure secondary to COVID on CPAP o NC anemia 2/2 suspected GIB patient expired 12/7/2021
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Type 2 diabetes mellitus, Upper respiratory tract infection
Clinical narrative: 88-year-old female with a history of hypertension, diabetes presents with generalized weakness. Patient has had cough, progressive weakness for the past 9 days. Patient presented to the primary care office 6 days ago and was diagnosed with a upper respiratory infection and given a Z-Pak. Patient has been taking this for the past 5 days with no improvement. Overnight patient has significant worsening of her weakness. Patient not initially complaining of any shortness of breath. On EMS arrival patient found to be 39% on room air. Patient is placed on 15 L nonrebreather O2 improved to 77%. Patient has no other complaints. Patient is vaccinated with Pfizer vaccine ×2. o New-onset atrial fibrillation; CHADS2Vasc =5.  ? Repeat limited 2D echo unchanged from 11/19/21 echo o DCCV 12/1 due to afib RVR with hypotension o Essential hypertension; BP labile, currently requiring vasopressors o DMII o Acute hypoxic respiratory failure secondary to COVID on CPAP o NC anemia 2/2 suspected GIB patient expired 12/7/2021
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Loss of consciousness, Malaise, Nausea
Clinical narrative: After vaccine administration, patient went to sit down for 15 min observation. After about 2 minutes patient passed out (fell asleep) on the chair and her friend called for help. Pharmacy staff called 911 and during the call in about 1 minute patient was awake and no longer in a fainting spell. EMS asked for patient to wait until they arrived. Her breathing was okay but patient complained that she felt sick--she was dizzy, lightheadedness, nausea and hot(face), blurry vision, and got extremely pale. Her temperature was 97.2. EMS arrived at around 1:08pm and stated will take her to the nearest hospital.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pallor, Vision blurred
Clinical narrative: After vaccine administration, patient went to sit down for 15 min observation. After about 2 minutes patient passed out (fell asleep) on the chair and her friend called for help. Pharmacy staff called 911 and during the call in about 1 minute patient was awake and no longer in a fainting spell. EMS asked for patient to wait until they arrived. Her breathing was okay but patient complained that she felt sick--she was dizzy, lightheadedness, nausea and hot(face), blurry vision, and got extremely pale. Her temperature was 97.2. EMS arrived at around 1:08pm and stated will take her to the nearest hospital.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Lot # 053E21A was administered outside the 30-day Use by Date.  A case was opened with Moderna ID Case ID CEA-1261.  "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (Covid-19) virus at time of administration."
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Booster dose given to child under age of 18- client was 14. This is not approved for this age group
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna covid 19 vaccine EUA. 0.5ml given instead of 0.25ml
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Computerised tomogram, Concussion, Electrocardiogram, Head injury
Clinical narrative: Fainting within less than 5 minutes of vaccination, very low heart rate, head injury, ambulance arrival and transport to Hospital where Patient received care. Laceration on head, low heart rate and concussion required Patient to be out of work, unable to drive and required PCP immediate follow-up.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate decreased, Impaired driving ability, Impaired work ability, Skin laceration, Syncope
Clinical narrative: Fainting within less than 5 minutes of vaccination, very low heart rate, head injury, ambulance arrival and transport to Hospital where Patient received care. Laceration on head, low heart rate and concussion required Patient to be out of work, unable to drive and required PCP immediate follow-up.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Fainting within less than 5 minutes of vaccination, very low heart rate, head injury, ambulance arrival and transport to Hospital where Patient received care. Laceration on head, low heart rate and concussion required Patient to be out of work, unable to drive and required PCP immediate follow-up.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cough, Death, Dyspnoea
Clinical narrative: pt diagnosed positive for COVID from PCP; to ED with increasing SOB, fever, cough, wheezing; hypoxic; placed on BIPAP, steroids; HRF and COVID pneumonia; given baricitinib; renal function worsened; hypotensive, vasopressors given; O2 saturation worsened; pt was DNR; pt's condition continued to decline and he passed away in the hospital
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Hypotension, Hypoxia, Oxygen saturation decreased, Positive airway pressure therapy
Clinical narrative: pt diagnosed positive for COVID from PCP; to ED with increasing SOB, fever, cough, wheezing; hypoxic; placed on BIPAP, steroids; HRF and COVID pneumonia; given baricitinib; renal function worsened; hypotensive, vasopressors given; O2 saturation worsened; pt was DNR; pt's condition continued to decline and he passed away in the hospital
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Renal impairment, SARS-CoV-2 test positive, Wheezing
Clinical narrative: pt diagnosed positive for COVID from PCP; to ED with increasing SOB, fever, cough, wheezing; hypoxic; placed on BIPAP, steroids; HRF and COVID pneumonia; given baricitinib; renal function worsened; hypotensive, vasopressors given; O2 saturation worsened; pt was DNR; pt's condition continued to decline and he passed away in the hospital
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID +
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna covid 19 vaccine EUA. 0.5ml given instead of 0.25ml
Age: 8.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue, Underdose
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine  Peds formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: positive covid test in fully vaccinated pt
Age: 6.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine (PEDS) pediatric formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9% NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9% NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient came in for the COVID vaccine booster. When in the clinic the patient received a dose at 0.3ml of the vaccine that was undiluted. The correct dose was provided, the wrong concentration was given.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Chest X-ray normal, Chills, Computerised tomogram normal, Confusional state
Clinical narrative: Pt.'s wife states that after receiving the 2nd dose of Moderna 03/10/2021, started experiencing symptoms 03/11/2021 of chills, confusion, and shortness of breath. Emergency Room visit 03/11/2021, Chest X-Ray, Cat Scan, and Blood Panel = Normal. Admitted for Observation at for 3 days. Symptoms have subsided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Urine analysis
Clinical narrative: Pt.'s wife states that after receiving the 2nd dose of Moderna 03/10/2021, started experiencing symptoms 03/11/2021 of chills, confusion, and shortness of breath. Emergency Room visit 03/11/2021, Chest X-Ray, Cat Scan, and Blood Panel = Normal. Admitted for Observation at for 3 days. Symptoms have subsided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure abnormal, Blood test, Pruritus, Rash, Sensitive skin
Clinical narrative: The rash I had after the second dose was worse than the first time, my skin is sensitive, it itches really bad, I have taken a steroid shot and three sets of steroid pills, I cannot take hot showers, I cannot stay focused on a single task. It is now December, and I still am dealing with the rash, and I take the cream as soon as I feel it coming on. I've also taken an allergy shot called Kenalog to help with the symptoms.  I've gained almost 25 pounds since then and it has affected my blood pressure as well.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Skin sensitisation, Weight increased
Clinical narrative: The rash I had after the second dose was worse than the first time, my skin is sensitive, it itches really bad, I have taken a steroid shot and three sets of steroid pills, I cannot take hot showers, I cannot stay focused on a single task. It is now December, and I still am dealing with the rash, and I take the cream as soon as I feel it coming on. I've also taken an allergy shot called Kenalog to help with the symptoms.  I've gained almost 25 pounds since then and it has affected my blood pressure as well.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Headache, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalization following COVID-19 vaccination. Admitted to the hospital on 12/8/2021 with chief complaint of SOA, fever, HA since yesterday. O2 74% on 2L in triage. Wears 2L at baseline. 93% on 6L in triage.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Lot # 053E21A was administered outside the 30-day Use by Date. A case was opened with Moderna ID Case ID CEA-1261. "The vaccine administered maintained the activity necessary to protect against the SARS-CoV-2 (Covid-19) virus at time of administration".
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mobility decreased, Nausea, Pain, Pain in extremity
Clinical narrative: I had a really sore arm, and I couldn't lift it. I ended up getting massages and it helped. I felt like I also had a fever and had a headache and felt nauseous as well and had a body ache. I rested for the weekend and took ibuprofen and was feeling normal the next Monday (except for my arm).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I had a really sore arm, and I couldn't lift it. I ended up getting massages and it helped. I felt like I also had a fever and had a headache and felt nauseous as well and had a body ache. I rested for the weekend and took ibuprofen and was feeling normal the next Monday (except for my arm).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Migraine
Clinical narrative: Migraine headache, sharp pains in the chest and upper back.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna covid 19 vaccine EUA. 0.5ml given instead of 0.25ml
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia
Clinical narrative: Hospitalized COVID-19 pneumonia
Age: 8.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine  Peds formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: 12/3/21 patient given Covid-19 vaccine second dose. Patient went to ER on 12/5/21 for hives all over body, they put her on hydralazine and five days of steroid. Patient then seen in PCP office 12/10/21 and told to take hydroxyzine for next few days and to call office if hives return, the hives have come and gone over last few days, since yesterday no more hives and patient doing well. ER advised not to get the Covid-19 booster vaccine.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Moderna covid 19 vaccine. 0.5ml given instead of 0.25ml
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever of 103.2°F
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal X-ray, Abdominal pain upper, Ageusia, Alanine aminotransferase normal, Aspartate aminotransferase increased
Clinical narrative: This is a 70y.o. female with a history of liver cirrhosis, PHG, esophageal varices, GERD, and former EtOH abuse (quit approx. 5 years ago per patient) who presents with complaint of nausea and generalized weakness. She states that her symptoms started on Friday 11/12/21. She reports a decrease in appetite, epigastric pain and loss of taste. Denies vomiting, diarrhea or constipation. Admits to one episode of hematuria on 11/16/21, mild shortness of breath and a non-productive cough that started around the same time. Her daughter at bedside states that the patient has been more fatigued and weak lately. Patient had difficulty walking ambulating today, so her daughter brought her to the ED for further evaluation. Patient received one dose of the COVID vaccine approximately 3 weeks ago. Denies fevers, chills, chest pain, headache, lightheadedness, dizziness, lower extremity edema.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, Bilirubin conjugated increased, Blood alkaline phosphatase increased, Blood bilirubin increased
Clinical narrative: This is a 70y.o. female with a history of liver cirrhosis, PHG, esophageal varices, GERD, and former EtOH abuse (quit approx. 5 years ago per patient) who presents with complaint of nausea and generalized weakness. She states that her symptoms started on Friday 11/12/21. She reports a decrease in appetite, epigastric pain and loss of taste. Denies vomiting, diarrhea or constipation. Admits to one episode of hematuria on 11/16/21, mild shortness of breath and a non-productive cough that started around the same time. Her daughter at bedside states that the patient has been more fatigued and weak lately. Patient had difficulty walking ambulating today, so her daughter brought her to the ED for further evaluation. Patient received one dose of the COVID vaccine approximately 3 weeks ago. Denies fevers, chills, chest pain, headache, lightheadedness, dizziness, lower extremity edema.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Fatigue, Gait disturbance
Clinical narrative: This is a 70y.o. female with a history of liver cirrhosis, PHG, esophageal varices, GERD, and former EtOH abuse (quit approx. 5 years ago per patient) who presents with complaint of nausea and generalized weakness. She states that her symptoms started on Friday 11/12/21. She reports a decrease in appetite, epigastric pain and loss of taste. Denies vomiting, diarrhea or constipation. Admits to one episode of hematuria on 11/16/21, mild shortness of breath and a non-productive cough that started around the same time. Her daughter at bedside states that the patient has been more fatigued and weak lately. Patient had difficulty walking ambulating today, so her daughter brought her to the ED for further evaluation. Patient received one dose of the COVID vaccine approximately 3 weeks ago. Denies fevers, chills, chest pain, headache, lightheadedness, dizziness, lower extremity edema.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Haematuria, Lipase normal, Lung opacity, Nausea, Oesophageal spasm
Clinical narrative: This is a 70y.o. female with a history of liver cirrhosis, PHG, esophageal varices, GERD, and former EtOH abuse (quit approx. 5 years ago per patient) who presents with complaint of nausea and generalized weakness. She states that her symptoms started on Friday 11/12/21. She reports a decrease in appetite, epigastric pain and loss of taste. Denies vomiting, diarrhea or constipation. Admits to one episode of hematuria on 11/16/21, mild shortness of breath and a non-productive cough that started around the same time. Her daughter at bedside states that the patient has been more fatigued and weak lately. Patient had difficulty walking ambulating today, so her daughter brought her to the ED for further evaluation. Patient received one dose of the COVID vaccine approximately 3 weeks ago. Denies fevers, chills, chest pain, headache, lightheadedness, dizziness, lower extremity edema.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: This is a 70y.o. female with a history of liver cirrhosis, PHG, esophageal varices, GERD, and former EtOH abuse (quit approx. 5 years ago per patient) who presents with complaint of nausea and generalized weakness. She states that her symptoms started on Friday 11/12/21. She reports a decrease in appetite, epigastric pain and loss of taste. Denies vomiting, diarrhea or constipation. Admits to one episode of hematuria on 11/16/21, mild shortness of breath and a non-productive cough that started around the same time. Her daughter at bedside states that the patient has been more fatigued and weak lately. Patient had difficulty walking ambulating today, so her daughter brought her to the ED for further evaluation. Patient received one dose of the COVID vaccine approximately 3 weeks ago. Denies fevers, chills, chest pain, headache, lightheadedness, dizziness, lower extremity edema.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule
Clinical narrative: SHE SAID SHE GOT A KNOT NEXT TO LEFT SHOULDER
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Joint stiffness, Loss of personal independence in daily activities
Clinical narrative: Joints very painful and stiff, fatigue interrupting with normal activity.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness transient, Deafness transitory, Hyperhidrosis, Syncope
Clinical narrative: Temporary loss of hearing Temporary loss of vision Sweating Fainting
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Laryngoscopy, Neck pain, Night sweats, Oropharyngeal pain
Clinical narrative: Somewhere around April 8th 2021, about 3 weeks after my second dose of the Covid 19 vaccine I began to develop unusual symptoms that lead me to contact my PCP for a medical evaluation: severe throat and sever neck pain, soaking night sweats, racing heart, and overall systemic pain. Upon completion of the examination, my doctor prescribed general flu like remedies and requesting for me to be re-evaluated in a weeks? time. I also had to call my cardiologist because the prescribed dosage of the beta blocker I take for an arrhythmia was suddenly no longer working. Not having any relief by the weeks end with any of my symptoms, my PCP doctor referred me to an ENT and my cardiologist altered the dosage of my medication to a higher dose. On April 15th an ENT performed a laryngoscopy. I was put on a 2 week regiment of clindamycin, to continue with my nasal fluticasone and to include some other throat remedies, since it was nearly impossible to swallow whole foods. At that time I was also advised to have a blood test performed by my PCP to monitor thyroid levels. On May 7, I had a blood test which revealed abnormally high thyroid levels along with multiple other abnormal blood levels, very unusual for my regular routine blood work. So the following week my PCP preformed the blood test again to check for possible error. The 2nd blood work verified the first and I was recommended I get a thyroid sonogram. My PCP with the agreement of the ENT, speculated that I had developed subacute thyroiditis. By July I started feeling better and my blood work had fortunately gone back to normal readings. September blood work as well. I recently had a new blood work and will receive the results soon.  I hope this information is of some value to your collection of data. I am extremely concerned regarding the 3rd booster which I have not received.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Palpitations, Thyroiditis subacute
Clinical narrative: Somewhere around April 8th 2021, about 3 weeks after my second dose of the Covid 19 vaccine I began to develop unusual symptoms that lead me to contact my PCP for a medical evaluation: severe throat and sever neck pain, soaking night sweats, racing heart, and overall systemic pain. Upon completion of the examination, my doctor prescribed general flu like remedies and requesting for me to be re-evaluated in a weeks? time. I also had to call my cardiologist because the prescribed dosage of the beta blocker I take for an arrhythmia was suddenly no longer working. Not having any relief by the weeks end with any of my symptoms, my PCP doctor referred me to an ENT and my cardiologist altered the dosage of my medication to a higher dose. On April 15th an ENT performed a laryngoscopy. I was put on a 2 week regiment of clindamycin, to continue with my nasal fluticasone and to include some other throat remedies, since it was nearly impossible to swallow whole foods. At that time I was also advised to have a blood test performed by my PCP to monitor thyroid levels. On May 7, I had a blood test which revealed abnormally high thyroid levels along with multiple other abnormal blood levels, very unusual for my regular routine blood work. So the following week my PCP preformed the blood test again to check for possible error. The 2nd blood work verified the first and I was recommended I get a thyroid sonogram. My PCP with the agreement of the ENT, speculated that I had developed subacute thyroiditis. By July I started feeling better and my blood work had fortunately gone back to normal readings. September blood work as well. I recently had a new blood work and will receive the results soon.  I hope this information is of some value to your collection of data. I am extremely concerned regarding the 3rd booster which I have not received.
Age: 7.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine Peds formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Patient was admitted for symptoms from COVID-19. This is considered a breakthrough case.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: Hospitalized worsening dyspnea and cough
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain, Lymphadenopathy, Tremor
Clinical narrative: severe shaking and chills for abut 2.5 hours extreme pain at injection site for 36 hours swollen glands both in upper arm and underarm on injected arm. extreme fatigue for 36 hours
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: I was to administer an adult dose of Pfizer COVID-19 vaccine for a second dose, and administered a Pediatric Pfizer COVID-19 dose by mistake. Patient stayed for the 15 min wait after getting the vaccine and did not have any type of reaction.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Electrocardiogram, Gait disturbance, Heart rate increased, Laboratory test
Clinical narrative: Booster dose Rapid Heart Rate, Difficulty walking, mental changes, New onset A-fib
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes
Clinical narrative: Booster dose Rapid Heart Rate, Difficulty walking, mental changes, New onset A-fib
Age: 9.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine (PEDS) pediatric formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9% NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9% NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Chest pain, Electrocardiogram, Fatigue
Clinical narrative: The day after the injection I experienced heart palpitations, fast heart rate, tired legs, and back pain. It worsened over the day over the next day. I went to urgent care a few days after the injection. I received a COVID test, EKG, and was sent to the emergency room to rule out blood clot. I also experienced pain over my sternum. I went to the local hospital and was told to follow up with a cardiologist. I was prescribed a "cardiac cocktail" and beta blockers to lower my heart rate. I started to experience neuropathy in my left leg. I saw my cardiologist May 2021. I was diagnosed with vaccine induced Lupus due to all of the symptoms and joint pain.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Neuropathy peripheral, Palpitations, SARS-CoV-2 test, Systemic lupus erythematosus
Clinical narrative: The day after the injection I experienced heart palpitations, fast heart rate, tired legs, and back pain. It worsened over the day over the next day. I went to urgent care a few days after the injection. I received a COVID test, EKG, and was sent to the emergency room to rule out blood clot. I also experienced pain over my sternum. I went to the local hospital and was told to follow up with a cardiologist. I was prescribed a "cardiac cocktail" and beta blockers to lower my heart rate. I started to experience neuropathy in my left leg. I saw my cardiologist May 2021. I was diagnosed with vaccine induced Lupus due to all of the symptoms and joint pain.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient and staff presented patient as an 11 year old person .  Age was confirmed with patient and they were vaccinated with Pfizer 5-11 vaccine.  Once documentation was completed, it was discovered the person was in fact over the age of 11.  Advised individual of issue and completed VAERS.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Polymenorrhoea
Clinical narrative: After taking the Moderna vaccines I have had multiple periods each month.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Urticaria
Clinical narrative: Patient got her second dose vaccine Pfizer on 11-15-2021 and on 12-2-2021 came to the pharmacy to report an adverse reaction that she got 3 days after her second dose.  Patient stated that she got hives on her arms, legs, elbows, thighs and joint.  she had aches as well.  she saw a doctor and gave her a steroid  treatment for it.  The patient said this rash was related to the vaccine, however, the doctor did not saying anything about this rash was related to the vaccine.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Dyspnoea exertional, SARS-CoV-2 test positive
Clinical narrative: Hospitalization with COVID-19 following vaccination. Admitted on 12/9/2021 with chief complaint of, "Pt tested positive for covid today, c/o SOA, worse with exertion."
Age: 5.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Patient received a dose of Pfizer COVID-19 Vaccine  formulation (5-11yr) that may have been reconstituted with a single use vial of 0.9%NS that was entered into multiple times to reconstitute other vials of Pfizer vaccine. Staff did not realize the 10mL vial was for single use only (to take out 1.3mL then discard). Each time the vial was used it was swabbed with alcohol and a new syringe was used to enter the vial then to add the diluent to the Pfizer vaccine for reconstitution. The 10mL, 0.9%NS vial was disposed of at the end of each day. The patient did not experience any adverse reaction. At the recommendation of Pfizer and the CDC, due to lack of stability data, it was advised to revaccinate the patient.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Electromyogram normal, Impaired work ability, Joint swelling, Neurological examination
Clinical narrative: Approximately 06/24/2021 but I really don't remember, I have been having dull pain on the side of both of my feet. My ankle was swollen really big. I have not been able to work because of this issue. 08/05/2021- Went to my primary doctor and informed her about my feet and they wanted to do a follow up a week later. 08/30/2021 I went back to see my doctor and was prescribed Gabapentin and Furosemide, was given a referral for an MRI appointment. Third appointment was 09/02/2021 it was a virtual appointment to follow up to see if the medication that was recently prescribed was working. I was advised at that time to take a higher dose of the medication. The medication was not working, and I can't remember the date that I spoke with the doctor, but I was advised to lower the doses. After about 2 to 3 weeks, I informed my doctor that the furosemide was not working either. I was then referred to a Neurologist and I was given an appointment for 11/15/2021. 11/18/2021 I was left with no insurance and because of that I cannot go get my MRI done on my neck and back on 12/17/2021. I was informed that the process for my insurance could take 30 days.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: Approximately 06/24/2021 but I really don't remember, I have been having dull pain on the side of both of my feet. My ankle was swollen really big. I have not been able to work because of this issue. 08/05/2021- Went to my primary doctor and informed her about my feet and they wanted to do a follow up a week later. 08/30/2021 I went back to see my doctor and was prescribed Gabapentin and Furosemide, was given a referral for an MRI appointment. Third appointment was 09/02/2021 it was a virtual appointment to follow up to see if the medication that was recently prescribed was working. I was advised at that time to take a higher dose of the medication. The medication was not working, and I can't remember the date that I spoke with the doctor, but I was advised to lower the doses. After about 2 to 3 weeks, I informed my doctor that the furosemide was not working either. I was then referred to a Neurologist and I was given an appointment for 11/15/2021. 11/18/2021 I was left with no insurance and because of that I cannot go get my MRI done on my neck and back on 12/17/2021. I was informed that the process for my insurance could take 30 days.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal wall oedema, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood fibrinogen normal, Blood lactate dehydrogenase increased
Clinical narrative: Pt is a61y.o. year old male presents to a local HCF due to progressive shortness of breath and increasing lower extremity and abdominal wall edema. He assumed his symptoms were all associated with relapsing CHF. ( patient with known ischemic cardiomyopathy/reduced EF, DM, Cirrhosis of liver.) He has tested positive for COVID 11/17. Patient believes he may have had onset of symptoms about 1 week ago. He has received 3 vaccines for COVID. I have counseled him regarding COVID disease and in view of his not requiring supplemental oxygen at this time I have presented the EUA criteria for Monoclonal antibody. The patient agrees with proceeding with MAB.   CXR 11/17 consistent with pulmonary vascular congestion COVID 19 INFLAMMATORY MARKERS: Recent Labs Component 11/17/21 1154 11/17/21 1111 11/17/21 0916 FERRITIN  --  262  --  AST  --   --  58* FIBRINOGEN 245  --   --  CK  --  418*  --  LDH  --  335*  --  CRP  --  41.8*  --    Procalcitonin Recent Labs Component 11/17/21 0916 PCTPL 0.37*
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Cardiac failure congestive, Chest X-ray abnormal, Dyspnoea
Clinical narrative: Pt is a61y.o. year old male presents to a local HCF due to progressive shortness of breath and increasing lower extremity and abdominal wall edema. He assumed his symptoms were all associated with relapsing CHF. ( patient with known ischemic cardiomyopathy/reduced EF, DM, Cirrhosis of liver.) He has tested positive for COVID 11/17. Patient believes he may have had onset of symptoms about 1 week ago. He has received 3 vaccines for COVID. I have counseled him regarding COVID disease and in view of his not requiring supplemental oxygen at this time I have presented the EUA criteria for Monoclonal antibody. The patient agrees with proceeding with MAB.   CXR 11/17 consistent with pulmonary vascular congestion COVID 19 INFLAMMATORY MARKERS: Recent Labs Component 11/17/21 1154 11/17/21 1111 11/17/21 0916 FERRITIN  --  262  --  AST  --   --  58* FIBRINOGEN 245  --   --  CK  --  418*  --  LDH  --  335*  --  CRP  --  41.8*  --    Procalcitonin Recent Labs Component 11/17/21 0916 PCTPL 0.37*
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Inflammatory marker test, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Oedema peripheral
Clinical narrative: Pt is a61y.o. year old male presents to a local HCF due to progressive shortness of breath and increasing lower extremity and abdominal wall edema. He assumed his symptoms were all associated with relapsing CHF. ( patient with known ischemic cardiomyopathy/reduced EF, DM, Cirrhosis of liver.) He has tested positive for COVID 11/17. Patient believes he may have had onset of symptoms about 1 week ago. He has received 3 vaccines for COVID. I have counseled him regarding COVID disease and in view of his not requiring supplemental oxygen at this time I have presented the EUA criteria for Monoclonal antibody. The patient agrees with proceeding with MAB.   CXR 11/17 consistent with pulmonary vascular congestion COVID 19 INFLAMMATORY MARKERS: Recent Labs Component 11/17/21 1154 11/17/21 1111 11/17/21 0916 FERRITIN  --  262  --  AST  --   --  58* FIBRINOGEN 245  --   --  CK  --  418*  --  LDH  --  335*  --  CRP  --  41.8*  --    Procalcitonin Recent Labs Component 11/17/21 0916 PCTPL 0.37*
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Pulmonary congestion, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Serum ferritin normal
Clinical narrative: Pt is a61y.o. year old male presents to a local HCF due to progressive shortness of breath and increasing lower extremity and abdominal wall edema. He assumed his symptoms were all associated with relapsing CHF. ( patient with known ischemic cardiomyopathy/reduced EF, DM, Cirrhosis of liver.) He has tested positive for COVID 11/17. Patient believes he may have had onset of symptoms about 1 week ago. He has received 3 vaccines for COVID. I have counseled him regarding COVID disease and in view of his not requiring supplemental oxygen at this time I have presented the EUA criteria for Monoclonal antibody. The patient agrees with proceeding with MAB.   CXR 11/17 consistent with pulmonary vascular congestion COVID 19 INFLAMMATORY MARKERS: Recent Labs Component 11/17/21 1154 11/17/21 1111 11/17/21 0916 FERRITIN  --  262  --  AST  --   --  58* FIBRINOGEN 245  --   --  CK  --  418*  --  LDH  --  335*  --  CRP  --  41.8*  --    Procalcitonin Recent Labs Component 11/17/21 0916 PCTPL 0.37*
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymph Nodes swollen around Left armpit
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Janssen dose give to 15 year old.  Indicated for 18 and over.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Retinal detachment, Retinopexy
Clinical narrative: Right retinal detachment
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine was beyond BUD.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Injection site pain, Paraesthesia, Paraesthesia oral
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: INCREASE IN HEART RATE-Mild, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: PT EXPERIENCED TONGUE TINGLING SINCE  VACCINATION IN ADDITION TO INCREASE IN HEART RATE
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state, Dysgeusia, Hypoaesthesia oral, Lethargy, Paraesthesia oral
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: INCREASE IN HEART RATE-Mild, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: PT EXPERIENCED TONGUE TINGLING SINCE  VACCINATION IN ADDITION TO INCREASE IN HEART RATE
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient admitted through ED for shortness of breath, cough, malaise, had tested positive for COVID 6 days prior and had received monoclonal antibody infusion as outpatient.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blindness, Cerebral haemorrhage, Headache
Clinical narrative: Booster dose of Pfizer given on 11/29/21. Was out with a friend on 11/30/21 and developed a severe headache and loss of sight. Went to local ER and was then transferred  to the Hospital.  DX of brain bleed. Was inpatient for 2 days.  Is back at home and doing well at this time.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Cases
Age: 11.0
Sex: F
Vaccine: MNQ, RAB
Symptoms: Blister, Erythema, Injection site erythema, Swelling
Clinical narrative: The patient c/o redness around the injection site on her right arm the evening she received the Menveo vaccine. By the next evening she had swelling and redness. Upon inspection she had a large pocket of fluid in her upper arm. Pt taken to pediatric urgent care by mother due to the amount of fluid on her arm She denied pain or tenderness and there were no signs of infection. Cold packs were given and Tylenol recommended. When seen in office 36 hours after administration, a large amount of fluid remained. We have ongoing monitoring.
Age: 6.0
Sex: M
Vaccine: HEPA, MMRV
Symptoms: Underdose
Clinical narrative: Patient was noncompliant during administration of MMRV vaccine and I was only able to administer half of the dose before he moved and I had to remove the needle. The provider was informed of this immediately and spoke with parents, who decided to come back in one month for a repeat dose. Patient left clinic about 5-10 minutes later and had no other issues.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dizziness, Fatigue, Pyrexia
Clinical narrative: Patient is a 83y.o. year old female admitted w/ CC as copied from DR. note of 11/17:"This is a 83y.o. female with hx HTN, COPD, presented to the ER with c/o weakness, dizziness, and a mild cough x 2 days.  EMS reported patient had a fever of 101.  She reports that she's been feeling weak and fatigued. She lives at an ECF. They provide and give her all her medications. She denies any associated HA, CP, SOB. No reported vomiting or diarrhea. She states she felt so weak that she thought she might fall. Denies any LE edema. No other complaints reported"   .Found to be COVID + w/ L basilar airspace dx on CXR   Discussed w/ Nursing - per their understanding, pt's 2L 02 via NC is, indeed, her baseline. Of note, 02 sat after trail of removal of supplemental 02 is 99%! Upon questioning pt further, however, she denies the use of supplemental 02
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Chills, Condition aggravated, Fatigue
Clinical narrative: Headache within 2 hours of receiving vaccine.  Resolved 3 hours after taking Advil.  Severe chills, arthralgia, weakness and fatigue within 6 hours of receiving the vaccine. Required Advil every 4 hours for about 24 hours.  Muscular soreness, minimal swelling at the incision site for 3 days. No redness.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site swelling, Myalgia
Clinical narrative: Headache within 2 hours of receiving vaccine.  Resolved 3 hours after taking Advil.  Severe chills, arthralgia, weakness and fatigue within 6 hours of receiving the vaccine. Required Advil every 4 hours for about 24 hours.  Muscular soreness, minimal swelling at the incision site for 3 days. No redness.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient received 2nd. dose of Pfizer on 8/26/21, only about 3.5 months out. No adverse effects currently from #3 dose.
Age: 62.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Hypoaesthesia, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Patient presented to ED for altered mental status, numbness, weakness. Subsequently found to be positive for COVID.